In addition, anti–PD-1 treatment was more impactful in nonobese females, which displayed increased infiltration of CD3+ and tumor antigen-specific CD8+ T cells, whereas this was not observed in obese females (Supplemental Figure 4B). Here, PDCD1 is linked to neoplasm.